StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SGHT·Healthcare

Sight Sciences, Inc. Stock Analysis & AI Score

Sight Sciences, Inc. (SGHT) has an ST Score of 43.8 (C), driven by its Momentum (A-) and held back by its Profitability (D+). Analysts rate it Buy with a $7.00 price target (-19.4% downside).

Market Closed
$8.68
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
44
ST Score
43.8/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SGHT
43.8out of 100
Grade C

Sight Sciences, Inc. (SGHT) has an ST Score of 43.8 (C), driven by its Momentum (A-) and held back by its Profitability (D+). Analysts rate it Buy with a $7.00 price target (-19.4% downside).

Strongest
MomentumA-
Weakest
ProfitabilityD+
All factor grades
  • MomentumA-
  • ValuationB-
  • Financial StrengthC
  • ForecastC
  • GrowthC-
  • ProfitabilityD+
  • Piotroski4/9
Score methodology
Press Releases

Contact

SGHT stock: frequently asked questions

What is SGHT's ST Score?

Sight Sciences, Inc. (SGHT) has an ST Score of 43.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SGHT a buy, hold, or sell?

Analysts rate SGHT a Buy, with a price target of $7.00 (-19.4% vs the current price). Our ST Score grades it C (43.8/100). The ST Score is a data-driven signal, not a recommendation.

What are SGHT's factor grades?

Valuation B-, Profitability D+, Financial Strength C, Momentum A-, Growth C-, Forecast C.

What is SGHT's valuation grade?

Sight Sciences, Inc. (SGHT) earns a valuation grade of B-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SGHT's growth grade?

Sight Sciences, Inc. (SGHT) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SGHT's profitability grade?

Sight Sciences, Inc. (SGHT) earns a profitability grade of D+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SGHT's financial strength grade?

Sight Sciences, Inc. (SGHT) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for SGHT?

The average analyst price target for Sight Sciences, Inc. (SGHT) is $7.00 from 9 analysts, which is -19.4% versus the recent price of $8.68.

What is SGHT's Piotroski score?

Sight Sciences, Inc. (SGHT) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.